A 2017 lawsuit alleging five pharmaceutical companies helped finance terror attacks against U.S. service members and other Americans in Iraq during the “War on Terror” was unanimously reinstated and remanded by a three-judge panel of the D.C. Court of Appeals. .
The lawsuit claims the five companies regularly paid bribes, including free drugs and medical devices, to officials in Iraq’s Ministry of Health between 2005 and 2011, in their efforts to secure drug contracts.
In turn, the suit alleges, these companies’ contracts with the Iraqi health ministry helped “fund terrorism” perpetrated by a Shiite militia that killed Americans during that period.
The militia in question, Jaysh al-Mahdi, or the “Mahdi Army,” maintained control of the health ministry at that time. The amended lawsuit was filed on behalf of 395 Americans who were killed or injured in Iraq during the six-year period.
According to the lawsuit, the pharmaceutical companies financially supported the Mahdi Army in two ways. One way was through bribes that were paid in the form of “discounts” — which were offered by the companies not through reduced prices, but through the provision of “free” medical goods, often equaling up to 20% of the total value of the contract.Pfizer, J&J Among Pharma Companies Accused of Funding Terrorism in Iraq • Children’s Health Defense